logo Novo Nordisk
Novo Nordisk is a global healthcare company headquartered in Denmark, recognized for pioneering insulin therapy and advancing treatments for obesity and serious chronic diseases. Our purpose is to drive change to defeat serious chronic diseases and create long-term health.

Role in the project

In BRIDGE, NOVO focuses on a strong support of the development of sandbox recommendations in WP4 and ensuring acceptance among stakeholders in WP5.